QQ客服 官方微博 反馈留言

	Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06)
	Lambertini, M.; Campbell, C.; Bines, J.; Korde, L.; Delso, M. A. Izquierdo; Fumagalli, D.; Pritchard, K.; Wolff, A.; Jackisch, C.; Lang, I.
	2017
卷号	28
ISSN号	0923-7534
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6363298
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Lambertini, M.,Campbell, C.,Bines, J.,et al. Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06)[J],2017,28.
APA	Lambertini, M..,Campbell, C..,Bines, J..,Korde, L..,Delso, M. A. Izquierdo.,...&De Azambuja, E..(2017).Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06).,28.
MLA	Lambertini, M.,et al."Adjuvant anti-HER2 therapy, treatment-induced amenorrhea (TIA) and survival in premenopausal patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the ALTTO trial (BIG 2-06)".28(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。